C3 and age-related macular degeneration: Even though the exact mechanism of complement system contribution to AMD is not fully understood there is significant amount of evidence linking C3 and its cleavage products with AMD, including genetic evidence [22, 23], elevated plasma levels [27, 28] and histological data [29, 30].